Skip to main content
. 2014 Nov 15;62:41–47. doi: 10.1016/j.jcv.2014.11.010

Table 1.

Demographics, underlying diseases/conditions, and categories of pneumonia.

Total
(n = 78)
Rhinovirus
(n = 27)
Influenza virus
(n = 51)
p-Value
Male sex 49 (62.8) 21 (77.8) 28 (54.9) 0.047
Age, median (interquartile range) 65.0 (53.8–71.0) 66.0 (57.0–70.0) 62.0 (53.0–73.0) 0.77



Underlying disease or conditiona
Structural lung disease 22 (28.2) 7 (25.9) 15 (29.4) 0.75
 Chronic obstructive lung disease 10 (12.8) 3 (11.1) 7 (13.7) 1.00
 Interstitial lung disease 7 (9.0) 4 (14.8) 3 (5.9) 0.23
 Bronchiectasis 4 (5.1) 1 (3.7) 3 (5.9) 1.00
 Destroyed lung due to tuberculosis 1 (1.3) 0 1 (2.0) 1.00
 Pneumoconiosis 1 (1.3) 0 1 (2.0) 1.00
Hematologic malignancy 18 (23.1) 11 (40.7) 7 (13.7) 0.007
Diabetes mellitus 16 (20.5) 7 (25.9) 9 (17.6) 0.39
Solid cancer 10 (12.8) 3 (11.1) 7 (13.7) 1.00
End-stage renal disease 2 (2.6) 0 2 (3.9) 0.54
Congestive heart failure 4 (5.1) 0 4 (7.8) 0.29
Liver cirrhosis 1 (1.3) 1 (3.7) 0 0.35
Chronic renal failure 3 (3.8) 0 3 (5.9) 0.55
s/p cerebraovascular attack 1 (1.3) 0 1 (2.0) 1.00
Solid organ transplantation 3 (3.8) 2 (7.4) 1 (2.0) 0.27
Hematopoietic stem cell transplantation 9 (11.5) 4 (14.8) 5 (9.8) 0.71
Immunocompromised stateb 39 (50.0) 22 (81.5) 17 (33.3) < 0.001
Receipt of immunosuppressant 21 (26.9) 14 (51.9) 7 (13.7) < 0.001
Recent chemotherapy 17 (21.8) 9 (33.3) 8 (15.7) 0.07
Active smoker 5 (6.2) 4 (14.8) 1 (1.9) 0.04
Ex-smoker 28 (35.9) 11 (40.7) 17 (33.3) 0.52
Recent surgery (within 1 month) 3 (3.8) 2 (7.4) 1 (2.0) 0.27
Neutropeniac 8 (10.3) 5 (18.5) 3 (5.9) 0.12



Category of pneumonia
Community-acquired pneumonia 22 (28.2) 3 (11.1) 19 (37.3) 0.02
Healthcare-associated pneumonia 31 (39.7) 15 (55.6) 16 (31.4) 0.04
Hospital-acquired pneumonia 25 (32.1) 9 (33.3) 16 (31.4) 0.86

Data are presented as No. (%) unless otherwise stated.

a

Some patients had one or more underlying diseases or conditions.

b

Defined as one of the following conditions: (i) daily receipt of immunosuppressants, including corticosteroids, (ii) human immunodeficiency virus infection, (iii) solid organ or hematopoietic stem cell transplant recipients, (iv) receipt of chemotherapy for underlying malignancy during the previous 6 months, and (v) underlying immune deficiency disorder.

c

Absolute neutrophil count < 500/mm3.